John David Boyle Net Worth & Insider Trades

John David Boyle - CEO, Avi Biopharma Inc

As of August 27, 2010

What is John David Boyle's Net Worth?

The current estimated net worth of Avi Biopharma Inc's CEO, John David Boyle, is estimated to be about $93.3K . John David Boyle owns about 70,282 units of Avi Biopharma Inc common stock. In the last year at Avi Biopharma Inc, John David Boyle has sold an estimated value of $0 worth.

What is John David Boyle's Past Insider Trading?

John David Boyle's largest purchase order was 19,000 units , worth over $12.14K on March 13, 2009. In total, John David Boyle has made about 6 transactions over a year of their time at Avi Biopharma Inc. John David Boyle usually trades in February and March, with the busiest year in 2010. The most recent transaction was a purchase order of 5,000 units , worth over $10.64K on August 27, 2010.

John David Boyle

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is John David Boyle's' Mailing Address?

  • Mailing address is Xoma Ltd 2910 Seventh Street Berkeley CA 94710 CA

What are Avi Biopharma Inc's Past Insider Trades?

Avi Biopharma Inc's most recent insider trade came on March 15, 2012 by Ben Gil Price who bought 30,000 units worth $38.85K . In the last 8 years, insiders at Avi Biopharma Inc have sold an estimated value of $13.48M and bought an estimated value of $5.78M worth of shares. Insider trading is most common in May, with the busiest year in 2010. The most active traders at the company are Leslie Hudson, Former CEO,  Ben Gil Price, Director,  and Dwight Weller, Sr. VP Chemistry & Mfg. .

AVI BIOPHARMA INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1